EZH2 and cancer: Epigenetic modifiers such as HATs, EZH2, SMRT, and TET1/2 are frequently mutated in human cancer, specifically in leukemia/lymphoma, carcinomas, and sarcomas, all of which are associated with severely altered transcription.